Innoviva Inc at Morgan Stanley Global Healthcare Conference Transcript
Great morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here. I'm pleased to have Innoviva with us for this session.
Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So with that out of the way, we can get started. So, Pavel, thanks for being here. Thanks for being with us.
Questions & Answers
And maybe just to kick us off, you have sort of a unique business model compared to a lot of the other companies. So maybe just talk about how you're balancing your royalty portfolio of income with some of the recent acquisitions you've made and how you're thinking about capital deployment more broadly.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
